Posts by Dana-Farber Cancer Institute
Vitamin D may protect against young-onset colorectal cancer
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps. …
Read Full ArticleBenefits of combination immunotherapy persist for more than six years in advanced melanoma
Nearly half of the patients who received combination immunotherapy for metastatic melanoma were alive a median of six and a half years after treatment. …
Read Full ArticleCAR T-cell therapy generates lasting remissions in patients with multiple myeloma
CAR T-cell therapy produces remissions in almost 75% of patients with relapsed treatment-resistant multiple myeloma. …
Read Full ArticleNew immunotherapy target discovered for malignant brain tumors
Scientists have discovered a potential new target for immunotherapy of malignant brain tumors. …
Read Full ArticlePersonalized vaccine produces long-lasting anti-tumor response in melanoma patients
Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response remains robust and effective in keeping cancer cells under control. …
Read Full ArticleNew evidence of health threat from chemicals in marijuana and tobacco smoke
Scientists have uncovered new evidence of the potential health risks of chemicals in marijuana and tobacco smoke. …
Read Full ArticleCAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma …
Read Full ArticleInherited pancreatic cancer risk mutation identified
Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers. …
Read Full ArticleChemotherapy drug found to spur immune system attack on lymphoma
Researchers demonstrate that large doses of cyclophosphamide not only kill cancer cells directly, as has been known, but also spur an immune system attack on the cells. …
Read Full ArticleTargeted therapy proves effective against aggressive rare blood cancer
A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN). …
Read Full Article